(19 Dec 18) Novartis Australia has announced the TGA approval of Kymriah® (tisagenlecleucel), for the…
Cell TherapiesDecember 19, 2018
Melbourne, Australia 26 June 2017: Cell Therapies has been awarded $1,000,000 in funding by the…
Cell TherapiesJune 26, 2017
Melbourne, Australia 20 February 2017: Cell Therapies commitment to, and excellence in, bringing innovative cellular…
Cell TherapiesFebruary 20, 2017
Melbourne, Australia, 11 October 2016: Cell Therapies Pty Ltd (CTPL) is pleased to announce that…
Cell TherapiesOctober 26, 2016
CT's contribution to ISCT 2016 Representatives from Cell Therapies presented at ISCT Singapore on the…
Cell TherapiesAugust 19, 2016
Melbourne 8 Feb 2016: Cell collection via apheresis is the starting point for manufacture of…
Cell TherapiesFebruary 8, 2016
REFORM NEEDED TO FULFILL OUR BIOTECH POTENTIAL is an article by AusBiotech’s Chief Executive, Dr…
Cell TherapiesOctober 7, 2015
Melbourne and Kuala Lumpur 30 Sep 2015: Cell Therapies Pty Ltd (CTPL) has today received…
Cell TherapiesOctober 5, 2015
Cell Therapies’ Chief Scientific Officer, Dr Dominic Wall will participate in AusBiotech2015 as part of…
Cell TherapiesSeptember 25, 2015
